Impact of Diabetes Mellitus on Percutaneous Coronary Intervention in Chinese Patients: A Large Single-Center Data

被引:13
作者
Wang, Huanhuan [1 ]
Gao, Zhan [1 ]
Song, Ying [1 ]
Tang, Xiaofang [1 ]
Xu, Jingjing [1 ]
Jiang, Ping [1 ]
Jiang, Lin [1 ]
Chen, Jue [1 ]
Gao, Lijian [1 ]
Song, Lei [1 ]
Zhang, Yin [1 ]
Zhao, Xueyan [1 ]
Qiao, Shubin [1 ]
Yang, Yuejin [1 ]
Gao, Runlin [1 ]
Xu, Bo [1 ]
Yuan, Jinqing [1 ]
机构
[1] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, A 167 Beilishi Rd, Beijing 100037, Peoples R China
基金
中国国家自然科学基金;
关键词
percutaneous coronary angioplasty; drug-eluting stent; diabetes mellitus; ELUTING STENT; RISK-FACTORS; OUTCOMES; DISEASE; REVASCULARIZATION; RESTENOSIS; THROMBOSIS; THERAPY;
D O I
10.1177/0003319717735226
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Aim: To investigate the impact of diabetic status on 2-year clinical outcomes in Chinese patients undergoing contemporary percutaneous coronary intervention (PCI) treatment. Methods and Results: A total of 10 724 consecutive patients underwent PCI at Fu Wai Hospital were prospectively collected. Two-year clinical outcomes were compared between patients with and without diabetes mellitus (DM). Diabetic patients had more baseline clinical risks and more extensive coronary disease. During 2-year follow-up, the rates of all-cause death, myocardial infarction (MI), revascularization, and major adverse cardiac events (MACE) were significantly higher in DM group. After multivariable-adjusted Cox regression analysis, DM was an independent risk factor for MACE but not for the individual components of MACE. After performing propensity score matching, rates of all-cause death, MI, revascularization, stroke, stent thrombosis, and MACE were not significantly different between the 2 groups, and DM was not predictive of MACE and any clinical adverse outcomes. Conclusions: Diabetic patients who underwent PCI had worse prognosis including death and repeat revascularization during 2-year follow-up, but DM was not an independent risk factor for adverse clinical outcomes.
引用
收藏
页码:540 / 547
页数:8
相关论文
共 28 条
  • [1] Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up from randomised trials
    Bangalore, Sripal
    Kumar, Sunil
    Fusaro, Mario
    Amoroso, Nicholas
    Kirtane, Ajay J.
    Byrne, Robert A.
    Williams, David O.
    Slater, James
    Cutlip, Donald E.
    Feit, Frederick
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [2] Long-term clinical and angiographic outcomes of diabetic patients after revascularization with early generation drug-eluting stents
    Billinger, Michael
    Raeber, Lorenz
    Hitz, Sarah
    Stefanini, Giulio G.
    Pilgrim, Thomas
    Stettler, Christoph
    Zanchin, Thomas
    Pulver, Cedric
    Pfaeffli, Nico
    Eberli, Franz
    Meier, Bernhard
    Kalesan, Bindu
    Jueni, Peter
    Windecker, Stephan
    [J]. AMERICAN HEART JOURNAL, 2012, 163 (05) : 876 - +
  • [3] Atherothrombosis, inflammation, and diabetes
    Biondi-Zoccai, GGL
    Abbate, A
    Liuzzo, G
    Biasucci, LM
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) : 1071 - 1077
  • [4] Diabetes and vascular disease -: Pathophysiology, clinical consequences, and medical therapy:: Part I
    Creager, MA
    Lüscher, TF
    Cosentino, F
    Beckman, JA
    [J]. CIRCULATION, 2003, 108 (12) : 1527 - 1532
  • [5] Clinical end points in coronary stent trials - A case for standardized definitions
    Cutlip, Donald E.
    Windecker, Stephan
    Mehran, Roxana
    Boam, Ashley
    Cohen, David J.
    van Es, Gerrit-Anne
    Steg, P. Gabriel
    Morel, Marie-angele
    Mauri, Laura
    Vranckx, Pascal
    McFadden, Eugene
    Lansky, Alexandra
    Hamon, Martial
    Krucoff, Mitchell W.
    Serruys, Patrick W.
    [J]. CIRCULATION, 2007, 115 (17) : 2344 - 2351
  • [6] Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement
    Elezi, S
    Kastrati, A
    Pache, J
    Wehinger, A
    Hadamitzky, M
    Dirschinger, J
    Neumann, FJ
    Schömig, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (07) : 1866 - 1873
  • [7] Strategies for Multivessel Revascularization in Patients with Diabetes
    Farkouh, Michael E.
    Domanski, Michael
    Sleeper, Lynn A.
    Siami, Flora S.
    Dangas, George
    Mack, Michael
    Yang, May
    Cohen, David J.
    Rosenberg, Yves
    Solomon, Scott D.
    Desai, Akshay S.
    Gersh, Bernard J.
    Magnuson, Elizabeth A.
    Lansky, Alexandra
    Boineau, Robin
    Weinberger, Jesse
    Ramanathan, Krishnan
    Sousa, J. Eduardo
    Rankin, Jamie
    Bhargava, Balram
    Buse, John
    Hueb, Whady
    Smith, Craig R.
    Muratov, Victoria
    Bansilal, Sameer
    King, Spencer, III
    Bertrand, Michel
    Fuster, Valentin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) : 2375 - 2384
  • [8] Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II
    Farooq, Vasim
    van Klaveren, David
    Steyerberg, Ewout W.
    Meliga, Emanuele
    Vergouwe, Yvonne
    Chieffo, Alaide
    Kappetein, Arie Pieter
    Colombo, Antonio
    Holmes, David R., Jr.
    Mack, Michael
    Feldman, Ted
    Morice, Marie-Claude
    Stahle, Elisabeth
    Onuma, Yoshinobu
    Morel, Marie-angele
    Garcia-Garcia, Hector M.
    van Es, Gerrit Anne
    Dawkins, Keith D.
    Mohr, Friedrich W.
    Serruys, Patrick W.
    [J]. LANCET, 2013, 381 (9867) : 639 - 650
  • [9] Diabetes and coronary revascularization
    Flaherty, JD
    Davidson, CJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (12): : 1501 - 1508
  • [10] Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents Prespecified Subgroup Analysis of the BIOSCIENCE Trial
    Franzone, Anna
    Pilgrim, Thomas
    Heg, Dik
    Roffi, Marco
    Tueller, David
    Vuilliomenet, Andre
    Muller, Olivier
    Cook, Stephane
    Weilenmann, Daniel
    Kaiser, Christoph
    Jamshidi, Peiman
    Raeber, Lorenz
    Stortecky, Stefan
    Wenaweser, Peter
    Jueni, Peter
    Windecker, Stephan
    [J]. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (06)